← back to search

Jinlong Yu

Harbin Medical University · CN
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Cell biology, Biology, Roux-en-Y anastomosis, Anastomosis, and Gastric bypass.
h-index
citations
195
works
10
NIH funding
primary concept
email

Recent publications

Mitigation of arteriosclerosis through transcriptional regulation of ferroptosis and lipid metabolism by magnesium
Biomaterials 2025cited by 10position: middledoi
New Mouse Models of Roux-en Y Gastric Bypass and One Anastomosis Gastric Bypass for Type 2 Diabetes
Obesity Surgery 2023cited by 3position: firstdoi
Classification Characteristics of COPD Based on Combination of Disease and Syndrome in Real World
2023cited by 1position: middledoi
Correction: New Mouse Models of Roux-en Y Gastric Bypass and One Anastomosis Gastric Bypass for Type 2 Diabetes
Obesity Surgery 2023cited by 0position: middledoi
Evaluation of early liquid drinking after radical gastrectomy in gastric cancer: a Chinese multicenter propensity score matching analysis
Gastroenterology report 2022cited by 5position: middledoi
Cx43 Inhibition Attenuates Sepsis-Induced Intestinal Injury via Downregulating ROS Transfer and the Activation of the JNK1/Sirt1/FoxO3a Signaling Pathway
Mediators of Inflammation 2019cited by 68position: lastdoi
Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson’s Disease
Molecular Neurobiology 2016cited by 34position: middledoi
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Cell Communication and Signaling 2014cited by 36position: firstdoi
Life and Death of Human Vascular Endothelial Cells by Stimulation with Free Fatty Acids Through Death Receptors
Hormone and Metabolic Research 2014cited by 2position: lastdoi
Slit2/Robo4 Signaling Modulates HIV-1 gp120-Induced Lymphatic Hyperpermeability
PLoS Pathogens 2012cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Heng Li · Shandong University2 papers (2023–2023) · 2 papers (2012–2014)Hongbin Zhang · Massachusetts Institute of Technology2 papers (2023–2023)Zhigao Song · The First Affiliated Hospital, Sun Yat-sen University2 papers (2023–2023)Liangping Wu · Guangzhou University of Chinese Medicine2 papers (2023–2023)Yunfa Ding · Guangzhou University of Chinese Medicine2 papers (2023–2023)Jipei He · Guangzhou University of Chinese Medicine2 papers (2023–2023)Hongyan Huang · Harvard University2 papers (2023–2023)Weiquan Zhu · University of Utah2 papers (2012–2014) · 2 papers (2012–2014)Dean Y. Li · Merck & Co., Inc., Rahway, NJ, USA (United States)2 papers (2012–2014)Tengfei Qi · Guangzhou University of Chinese Medicine2 papers (2023–2023)Qing Liu · People’s Hospital of Rizhao2 papers (2023–2023)Nuomin Li · Chinese PLA General Hospital1 papers (2016–2016)Yunming Xiao · Chinese PLA General Hospital1 papers (2014–2014)Xuezhong Zhou · Dalian Medical University1 papers (2023–2023)Nian Xiong · Wuhan Red Cross Hospital1 papers (2016–2016)Junjiang Wang · University of California, Davis1 papers (2022–2022)Ole Isacson · Harvard Stem Cell Institute1 papers (2016–2016)Jie Li · Jiangsu University1 papers (2016–2016)